Tapentadol Retard Laboratorios Liconsa 50 mg tabl. prol.-rel.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Tapentadol Tartrate 83,905 mg - Eq. Tapentadol 50 mg

MAH:

Laboratorios Liconsa S.A.

ATC_code:

N02AX06

pharmaceutical_form:

Prolonged-release tablet

administration_route:

Oral use

therapeutic_area:

Tapentadol

leaflet_short:

CTI Extended: 600666-04; 600666-03; 600666-05; 600666-02; 600666-01

authorization_status:

Commercialised: No

authorization_date:

2022-06-20